Crohn Colitis
12
2
2
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.3%
1 terminated out of 12 trials
75.0%
-11.6% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (12)
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis
High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD)
Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
A Pilot Study to Explore the Role of Gut Flora in Crohn's Disease
Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease
Investigation of VAP-1 Expression and Tissue Blood Flow by PET-MRI in Patients With Crohn's Disease
The Mind-Body IBD Study: Understanding the Mind-body Connection in IBD
Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD
OPtical Diagnosis Training to Improve Dysplasia Characterisation in IBD
Objective Perfusion Rate Assessment by Near-infrared Fluorescence in Ileal Pouch Formation and Ileal-pouch-anal Anastomosis
Subjective Near-infrared Fluorescence Guidance in Perfusion Assessment of Ileal Pouch Formation and Ileal-pouch-anal Anastomosis